MEDICARE PRESCRIPTION DRUG, IMPROVEMENT, AND MODERNIZATION ACT

Amendments

Enact (H.R. 1): consideration of conference report (H. Res. 463), H12245 [21NO]

Articles and editorials

AARP Accused of Conflict of Interest, H12254 [21NO]

AARP Calls on Vermont Congressional Delegation To Vote for Medicare Rx Bill, S15694 [24NO]

Drugmakers Protect Their Turf—Medicare Bill Represents Success for Pharmaceutical Lobby, H12110 [21NO]

Hobson's Medicare, S15897 [25NO]

Medicare Bill Would Enrich Companies, S15724 [24NO]

Medicare Debate Turns to Pricing of Drug Benefits, S15735 [24NO]

Medicare Reform—Try Again, S15909 [25NO]

2 Bills Would Benefit Top Bush Fundraisers—Executives' Companies Could Get Billions, S15558 [22NO], S15728 [24NO]

When Half a Loaf Isn't Nearly Enough, S15606 [23NO]

Bills and resolutions

Congress: tribute to staffs of the Offices of the Legislative Counsel of the Senate and the House of Representatives (see S. Res. 277), S15976 [25NO]

Enact (H.R. 1): consideration of conference report (see H. Res. 463), H12306 [21NO]

———consideration of conference report (H. Res. 463), same-day consideration (see H. Res. 459), H11700 [20NO]

Improve (see S. 1974), S15975 [25NO]

Medicare: eliminate privatization, improve prescription drug benefit, and repeal health savings accounts (see S. 1992), S16120 [9DE]

———permit the Dept. of HHS to enter into direct negotiations to promote the best prices for beneficiaries (see H.R. 3671), H12918 [8DE]

———provide for negotiation of fair prices for prescription drugs (see S. 1994, 1999), S16120 [9DE] (see H.R. 3672), H12918 [8DE]

———repeal Medicare Advantage Regional Plan Stabilization Fund (see S. 1995), S16120 [9DE]

Cloture motions

Enact (H.R. 1): conference report, S15561 [22NO], S15698 [24NO]

Conference reports

Provisions (H.R. 1), H11877-H12103 [20NO]

Letters

Enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs: Timothy J. Muris, FTC, S15886 [25NO]

Medicare coverage of drug treatment therapy for HIV/AIDS patients: Tommy G. Thompson, Sec. of HHS, S15888 [25NO]

Medicare payments to rural health care providers and facilities: Kimberly A. Russel and Kirk Norris, Iowa Hospital Association, S15580 [22NO]

Provisions: Edward G. Rendell, Governor of Pennsylvania, H12252 [21NO]

———Gary Locke, Tom Vilsack and Bill Richardson, Democratic Governors' Association, S15636 [23NO]

———Jeb Bush, Governor of Florida, H12243 [21NO]

———John Yoo, S15752-S15755 [24NO]

———Republican Governors Association, H12243 [21NO]

———several Members of Congress, S15536 [22NO]

———several Representatives, H12109, H12184 [21NO]

———several Senators, S15536 [22NO], S15897 [25NO]

Lists

Senate and House staff members who contributed to H.R. 1, provisions, S15914 [25NO]

Votes on point of order against Greater Access to Affordable Pharmaceuticals Act (2002), S15702 [24NO]

Motions

Enact (H.R. 1): conference report, S15698 [24NO], H12294 [21NO]

Press releases

Provisions: Iowa Hospital Association, S15580 [22NO]

Questions and answers

Access to HIV/AIDS drugs under H.R. 1, provisions: Senator Feinstein and Tommy G. Thompson, Sec. of HHS, S15597 [23NO]

Remarks in House

AARP: alleged conflict of interest relative to endorsement of Medicare reform and prescription drug coverage, H12253 [21NO]

Dept. of HHS: promulgate regulations for the reimportation of prescription drugs, H12106, H12178 [21NO]

Enact (H.R. 1): conference report, H11362 [18NO], H12106, H12107, H12108-H12113, H12184, H12185, H12247-H12297 [21NO], H12750, H12752, H12761, H12846-H12854, H12879, H12883, H12901-H12908 [8DE], E2455 [25NO], E2474 [8DE]

———conference report, unanimous-consent agreement, H12239 [21NO]

———consideration of conference report, H12230-H12246 [21NO]

———consideration of conference report (H. Res. 463), same-day consideration (H. Res. 459), H12174-H12181 [21NO]

House of Representatives: bribery allegations relative to Representative Nick Smith's vote on Medicare Prescription Drug, Improvement, and Modernization Act, H12750, H12905 [8DE]

Medicare: improve access to services in rural hospitals and critical access hospitals, H12106 [21NO]

———increase payments to rural health care providers and facilities, H12241 [21NO]

———provide for expeditious coverage of new medical technology, H12294 [21NO]

New Jersey: impact of Medicare legislation on Pharmaceutical Assistance to the Aged & Disabled (PAAD) program, H12262 [21NO]

Pharmaceuticals: require manufacturers to sell FDA-approved prescription drugs to U.S. wholesalers and retailers on the same terms as Canadian purchasers, H12752 [8DE]

Remarks in Senate

AARP: alleged conflict of interest relative to endorsement of Medicare reform and prescription drug coverage, S15729 [24NO]

Congress: tribute to efforts of staff involved in passage, S15913, S15930-S15932, S15950 [25NO]

———tribute to staffs of the Offices of the Legislative Counsel of the Senate and the House of Representatives (S. Res. 277), S16062 [25NO]

Dept. of HHS: promulgate regulations for the reimportation of prescription drugs, S15531 [22NO]

Drugs: enhance competition for prescription drugs by increasing enforcement of existing antitrust laws relative to brand name and generic drugs, S15884-S15886 [25NO]

Enact (H.R. 1): conference report, S15373-S15376, S15379-S15385, S15399 [21NO], S15514, S15519, S15521-S15569, S15574-S15588 [22NO], S15592-S15644, S15663-S15667 [23NO], S15670-S15771 [24NO], S15882-S15902, S15904-S15915, S15918, S15919, S15927-S15932, S15950 [25NO], S16104-S16107 [9DE]

———conference report, unanimous-consent agreement, S15510 [21NO], S15528 [22NO]

Improve (S. 1974), S16022 [25NO]

Medicare: clarification of a hospital ``under development'' relative to exemption from the self-referral limitation, S15743 [24NO]

———coverage of cancer drugs and treatments, S15739, S15740 [24NO]

———coverage of drug treatment therapy for HIV/AIDS patients, S15596 [23NO], S15887, S15888 [25NO]

———definition of negotiated price for drug coverage relative to inclusion of dispensing fees, S15742, S15743 [24NO]

———eliminate privatization, improve prescription drug benefit, and repeal health savings accounts (S. 1992), S16127 [9DE]

———ensure beneficiaries have convenient access to retail pharmacies for prescription drug coverage and prohibit the tying of contracts by health plans, S15743 [24NO]

———improve reimbursement payments to physicians, S15399 [21NO]

———increase payments to rural health care providers and facilities, S15579 [22NO]

———provide for negotiation of fair prices for prescription drugs (S. 1994), S16133 [9DE]

———provide for negotiation of fair prices for prescription drugs (S. 1999), S16138 [9DE]

———reform reimbursement rates for chemotherapy drugs and administration, S15887 [25NO]

———repeal Medicare Advantage Regional Plan Stabilization Fund (S. 1995), S16133 [9DE]

Taxation: treatment of company-owned life insurance, S15886, S15887 [25NO]

Reports

Impact of Republican Medicare Proposals on Insurance Industry Revenues and Profits: Committee on Health, Education, Labor, and Pensions (Senate) Minority Staff, S15769 [24NO]

Reports filed

Consideration of Conference Report on H.R. 1, Provisions: Committee on Rules (House) (H. Res. 463) (H. Rept. 108-394), H12306 [21NO]

Provisions: Committee of Conference (H.R. 1) (H. Rept. 108-391), H11700 [20NO]

Same-Day Consideration of H. Res. 463, Consideration of Conference Report on H.R. 1, Provisions: Committee on Rules (House) (H. Res. 459) (H. Rept. 108-390), H11700 [20NO]

Summaries

Defense of Medicare and Real Medicare Prescription Drug Benefit Act (S. 1992), S16128 [9DE]

Texts of

H. Res. 459, same-day consideration of H. Res. 463, consideration of conference report on H.R. 1, provisions, H12174 [21NO]

H. Res. 463, consideration of conference report on H.R. 1, provisions, H12230 [21NO]

S. 1974, Medicare Preservation and Drug Price Fairness Act, S16022 [25NO]

S. 1994, Efficiency in Government Health Care Spending Act, S16133 [9DE]

S. 1995, repeal Medicare Advantage Regional Plan Stabilization Fund, S16133 [9DE]

S. Res. 277, tribute to staffs of the Offices of the Legislative Counsel of the Senate and the House of Representatives, S16031, S16062 [25NO]